Medical news

The SMART-DECISION Study: Discontinuation of Beta-Blockers After Myocardial Infarction

July 11, 2026Diego Herrera1 мин

The SMART-DECISION study, a significant research initiative conducted in South Korea, investigated the feasibility of discontinuing beta-blocker therapy in a specific patient population. Specifically, the research focused on individuals who had experienced a myocardial infarction (heart attack) but were considered stable and at low cardiovascular risk. All participants had been on beta-blocker treatment for at least one year following the cardiac event. This study aims to provide clarity on a relevant clinical question regarding long-term post-infarction care.